These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 18552058

  • 1. [Lymphoma in patients who have undergone organ transplantation: severe and variable clinical presentation].
    Bakker NA, van Imhoff GW, van Son WJ, Kluin PM, Kluin-Nelemans JC, Verschuuren EA.
    Ned Tijdschr Geneeskd; 2008 May 10; 152(19):1077-80. PubMed ID: 18552058
    [Abstract] [Full Text] [Related]

  • 2. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 3. Posttransplant lymphoproliferative disorder.
    Everly MJ, Bloom RD, Tsai DE, Trofe J.
    Ann Pharmacother; 2007 Nov 10; 41(11):1850-8. PubMed ID: 17940127
    [Abstract] [Full Text] [Related]

  • 4. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL, Marcus R, Bradley JA.
    Crit Rev Oncol Hematol; 2005 Oct 10; 56(1):155-67. PubMed ID: 15979320
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 10; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 6. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
    Knoop C, Kentos A, Remmelink M, Garbar C, Goldman S, Feremans W, Estenne M.
    Clin Transplant; 2006 Feb 10; 20(2):179-87. PubMed ID: 16640524
    [Abstract] [Full Text] [Related]

  • 7. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD, Hunger SP, Braylan RC, Dharnidharka VR.
    Transpl Infect Dis; 2008 Dec 10; 10(6):426-30. PubMed ID: 18657087
    [Abstract] [Full Text] [Related]

  • 8. Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation.
    Taylor AL, Bowles KM, Callaghan CJ, Wimperis JZ, Grant JW, Marcus RE, Bradley JA.
    Transplantation; 2006 Aug 15; 82(3):375-81. PubMed ID: 16906036
    [Abstract] [Full Text] [Related]

  • 9. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Roque J, Rios G, Humeres R, Volpi C, Herrera JM, Schultz M, Rios H, Rius M, Salgado C, Hepp J.
    Transplant Proc; 2006 Apr 15; 38(3):930-1. PubMed ID: 16647513
    [Abstract] [Full Text] [Related]

  • 10. Post-transplant lymphoproliferative disorders of oral cavity.
    Ojha J, Islam N, Cohen DM, Marshal D, Reavis MR, Bhattacharyya I.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May 15; 105(5):589-96. PubMed ID: 18442744
    [Abstract] [Full Text] [Related]

  • 11. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
    Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J.
    Am J Pathol; 1988 Oct 15; 133(1):173-92. PubMed ID: 2845789
    [Abstract] [Full Text] [Related]

  • 12. Rituximab in association with rapamycin for post-transplant lymphoproliferative disease treatment.
    Garcia VD, Bonamigo Filho JL, Neumann J, Fogliatto L, Geiger AM, Garcia CD, Barros V, Keitel E, Bittar AE, Ferrera des Santos A, Roithmann S.
    Transpl Int; 2003 Mar 15; 16(3):202-6. PubMed ID: 12664217
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus T-cell immunity despite rituximab.
    Nehring AK, Dua U, Mollee P, Gill D, Grimmett K, Khanna R, Moss D, Gandhi MK.
    Br J Haematol; 2007 Feb 15; 136(4):628-32. PubMed ID: 17223914
    [Abstract] [Full Text] [Related]

  • 14. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ.
    Transpl Int; 2007 Mar 15; 20(3):207-18. PubMed ID: 17291214
    [Abstract] [Full Text] [Related]

  • 15. Aggressive posttransplant lymphoproliferative disease in a renal transplant patient treated with alemtuzumab.
    Muzaffar M, Taj A, Ratnam S.
    Am J Ther; 2010 Mar 15; 17(6):e230-3. PubMed ID: 19918163
    [Abstract] [Full Text] [Related]

  • 16. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
    Brunner B, Kropshofer G, Ellemunter H, Brunner A, Mueller T, Margreiter R, Tzankov A.
    Pediatr Transplant; 2007 Aug 15; 11(5):547-51. PubMed ID: 17631026
    [Abstract] [Full Text] [Related]

  • 17. Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.
    Lee JJ, Lam MS, Rosenberg A.
    Ann Pharmacother; 2007 Oct 15; 41(10):1648-59. PubMed ID: 17848421
    [Abstract] [Full Text] [Related]

  • 18. Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases.
    Lorenzini S, Andreone P, Gramenzi A, Morelli C, Zinzani PL, Grazi GL, Pileri S, Baccarani M, Tura S, Bernardi M.
    Transplant Proc; 2006 Jun 15; 38(5):1477-80. PubMed ID: 16797338
    [Abstract] [Full Text] [Related]

  • 19. [The spectrum of lymphoproliferations and malignant lymphoma after organ transplant].
    Müller-Hermelink HK, Ott G, Kneitz B, Rüdiger T.
    Verh Dtsch Ges Pathol; 2004 Jun 15; 88():63-8. PubMed ID: 16892535
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Sack FU, Schnabel P, Schnitzler P, Katus HA, Dengler TJ.
    Transpl Int; 2008 Oct 15; 21(10):963-71. PubMed ID: 18564989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.